Previously, a 32 base pair deletion in the CCR5 gene (CCR5-delta32), leading to a truncated gene product, had been shown to confer marked protection against HIV-1 infection in homozygous individuals, while infected heterozygotes show substantially delayed progression of the infection [2,3]. Here, CCR5 is linked to HIV-1 infection.